8|0|Public
6000|$|... [133] [...] "Ce n'est point à l'assemblée entière que je m'adresse ici; je ne parle qu'à ceux qui l'égarent, en lui cachant sous des gazes séduisantes le but où ils l'entraînent. C'est à eux que je dis: Votre objet, vous n'en disconviendrez pas, c'est d'ôter tout espoir au clergé, et de <b>consommer</b> sa ruine; c'est-là, en ne vous soupçonnant d'aucune {{combinaison}} de cupidité, d'aucun regard sur le jeu des effets publics, c'est-là ce qu'on doit croire que vous avez en vue dans la terrible opération que vous proposez; c'est ce qui doit en être le fruit. Mais le peuple qui vous y intéressez, quel avantage peut-il y trouver? En vous servant sans cesse de lui, que faites-vous pour lui? Rien, absolument rien; et, au contraire, vous faites ce qui ne conduit qu'à l'accabler de nouvelles charges. Vous avez rejeté, à son préjudice, une offre de 400 millions, dont l'acceptation pouvoit devenir un moyen de soulagement en sa faveur; et à cette ressource, aussi profitable que légitime, vous avez substitué une injustice ruineuse, qui, de votre propre aveu, charge le trésor public, et par consequent le peuple, d'un surcroît de dépense annuelle de 50 millions an moins, et d'un remboursement de 150 millions.|$|E
5000|$|À <b>consommer</b> avec modération (Consume with Moderation) Paris,Editions Odile Jacob (2005) ...|$|E
5000|$|Fr. À <b>consommer</b> avant … (lit. ‘To consume before …’) :on a {{container}} of packaged food ...|$|E
50|$|In 1998, {{he participated}} in Goldman's album En passant and in the tour that followed. In 2001, {{he participated in}} Goldman's album Chanson pour les pieds and in the tour that followed. In {{addition}} to his work with Goldman, he continued a solo career, releasing A <b>consommer</b> sans modération in 1997, and Prises et reprises in 2004.|$|E
40|$|Meat & Livestock Australia and Meat Standards Australia and INRA have {{organized}} an International meeting on Beef and Lamb carcass grading to underpin consumer satisfaction. The 2 day meeting consisted of 19 presentations centred {{on the theme}} that modern beef and lamb products must meet the expectations of consumers who purchase red meat to cook it as a meal solution. The focus was based around the Meat Standards Australia (MSA) grading platform which is designed as a sensory or eating quality grading system for underpinning a cooked meal performance that is matched to the occasion and requires no specialist knowledge by the consumer. This workshop unanimously supported the need for evidence based systems to underpin eating quality for lamb and beef {{in order to keep}} consumers purchasing products that are higher in price than the white meat competitors. Registrations were received from 80 people covering 17 countries (Australia, Brazil, Canada, China, Czech Republic, Denmark, France, Italy, Japan, Republic of Ireland, Poland, Portugal, South Africa, Spain, Thailand, United Kingdom, United States of America) creating a dynamic workshop atmosphere. In order to drive and focus the recommendations which were discussed {{at the end of the}} workshop, it was agreed to establish a working group of current collaborating countries that would be open with respect to new partners. Le « Meat Livestock Australia » et l’INRA ont organisé un congrès international sur la prédiction de la qualité sensorielle de la viande bovine et ovine pour le consommateur. Durant deux jours, 19 présentations ont souligné que, de nos jours, la viande de ruminant doit répondre aux attentes gustatives des consommateurs qui achètent de la viande rouge pour leurs repas. L'accent a été mis sur le système de prédiction de la qualité MSA (pour Meat Standards Australia) qui a été conçu comme un système de prévision de la qualité sensorielle pour les viandes cuites à <b>consommer</b> dans diverses occasions sans pour autant nécessiter de connaissances spécifiques de la part des consommateurs. Ce congrès a reconnu unanimement la nécessité d’un tel système de prédiction de la qualité des viandes bovines et ovines afin de fidéliser les acheteurs parfois tentés de <b>consommer</b> des viandes blanches moins chères. Les 80 participants au congrès de 17 pays (Australie, Brésil, Canada, Chine, République tchèque, Danemark, France, Italie, Japon, Irlande, Pologne, Portugal, Afrique du Sud, Espagne, Thaïlande, Royaume-Uni, USA) ont travaillé de façon dynamique et collective. En effet, il a été décidé de créer un groupe de travail international avec les pays actuellement impliqués tout en étant ouvert à de nouveaux partenaires afin de mettre en oeuvre les recommandations issues du congrès...|$|E
40|$|La consommation et la dépendance aux drogues furent {{longtemps}} considérées comme un problème typiquement masculin. Néanmoins, bien que l’abus et la dépendance à l’alcool, au cannabis et à la nicotine soient encore plus répandus chez {{les hommes}}, les différences de genre {{en ce qui concerne}} les stimulants et les opiacés ont largement disparu. Il semblerait également que les motivations pour commencer à <b>consommer,</b> l’escalade vers la dépendance et les taux de cessation diffèrent chez les hommes et les femmes. Les raisons qui expliquent ces différences sont multiples et complexes. Nous allons examiner ici les données des études épidémiologiques et cliniques concernant la consommation de diverses drogues chez des hommes et chez des femmes en contexte des facteurs socioculturels, psychologiques et neurobiologiques. Drug use and drug addiction have been traditionally {{considered to be}} a male problem, however the gender gap has been decreasing over the past few decades. Thus, while the prevalence of alcohol, cannabis and nicotine dependence is still overall greater among men than among women, sex/gender differences in the abuse of stimulants and opiates seem to have disappeared. Moreover, women appear to be more prone to develop drug dependence, suffer more severe physical and psychological consequences of drug abuse, and have more difficulties quitting the habit. Numerous psychological, socio-cultural and biological factors have been implicated in these changing statistics. For example, while a large proportion of men initiate drug use to induce feelings of elation, energy or focus, women frequently start taking drugs to alleviate pre-existing mental health problems, including high levels of stress, feelings of alienation, depression, anxiety, or post-traumatic stress disorder. This maladaptive self-medication strategy often results in a faster transition to a habitual drug use and eventually a more severe dependence. In addition, the socio-cultural norms (particularly in the Western society) have changed dramatically over the past few decades. Thus, while there is still a more severe stigma and prejudice against women who use drugs (especially if they are pregnant of have children), overall there is much greater acceptance of women’s drug use than it was several decades ago. Moreover, women have much greater access to various drugs of abuse than they used to have. Finally, {{over the past couple of}} decades new research started emerging pointing to some neurobiological factors that could also contribute to sex differences in drug addiction. Thus, there is now evidence that dopamine system, which for decades has been strongly implicated in drug reinforcement, is sexually dimorphic. The number of dopaminergic neurons, the density of the dopaminergic terminals, as well as responsiveness of the dopaminergic system to drugs of abuse, has been shown to differ between males and females and it has been shown to be modulated by sex steroid hormones, especially estrogen. For example, female rats exhibit greater motivation to self-administer cocaine than male rats and their motivation is the highest during elevated levels of estrogen. All these psychological, socio-cultural and biological factors that contribute to sex/gender difference in drug use and drug dependence, should be considered while evaluating and treating individuals with drug addiction problem...|$|E
40|$|Le craving, ce désir intense de <b>consommer,</b> est un symptôme central de la toxicomanie. Jusqu’au début des années 2000, peu d’outils existaient afin d’étudier le phénomène de manière plus concrète pour mieux le définir, le comprendre et approfondir les fondements neurobiologiques qui le sous-tendent. Avec les avancées technologiques des dernières années (IRM fonctionnelle, PET Scan), puis l’arrivée du DSM-V et son {{inclusion}} comme critère diagnostique des troubles liés à l’utilisation de substances, le craving est devenu un symptôme central en toxicomanie. Sa définition a évolué et est de plus en plus précise à plusieurs égards. Nous avons une meilleure compréhension des voies neurobiologiques impliquées dans le phénomène ainsi qu’une meilleure compréhension des facteurs capables de le déclencher. Finalement, plusieurs travaux ont évoqué le rôle du craving dans la rechute lors de l’abstinence, et quelques traitements pharmacologiques se sont démontrés efficaces afin d’atténuer ce symptôme et éviter la rechute. Le craving s’avère ainsi une cible de choix afin de trouver de nouvelles avenues thérapeutiques pour briser le cycle de la dépendance. Objective: Observed {{by physicians}} and often reported by patients, craving is a core symptom of addiction, although not well defined nor understood completely. In {{the last several}} years, functional imaging {{as well as the}} measurement of different biological substrates of addiction have greatly evolved, allowing for {{a better understanding of the}} underlying neurobiological pathways of craving. Furthermore, with the development of the DSM-V and its inclusion as a diagnostic criterion for substance use disorders, craving has gained a whole new level of interest. Hence, the general objective of this article is to examine findings of studies that have led to a better understanding of craving and its implications. First, we address the definition of craving and its epidemiology in individuals with substance use disorders. We then summarize the results of the research conducted on the neurobiological substrates of craving. Finally, we present the role of craving in the cycle of addiction and its potential as a therapeutic target for pharmacological and non-pharmacological interventions. Methods: Narrative review of the literature. Results: The definition of craving has greatly evolved throughout the years, and it is commonly described as an abnormal desire or need to take a drug. While its conscious aspect is well known, whereas it is expressed subjectively, it is growingly also defined as an unconscious phenomenon illustrated by a physiologic activation that is not perfectly correlated with subjective measures. Available data on craving have also demonstrated the presence of this symptom in all three phases of the addiction cycle, including early and prolonged abstinence, long after the acute physical withdrawal syndrome. Three factors have been identified as potent craving inducers: the drug itself, drug related cues and stress. PET scan studies and fMRI studies confirmed the implication of dopaminergic pathways in craving, and have more recently shed light on the contribution of other neurotransmission systems, such as GABA, norepinephrine as well as the endocannabinoid and opioid systems, but their roles are not yet fully understood. Furthermore, craving-related activations of specific areas of the brain involved in learned habits and behavior as well as memory have been demonstrated by various studies; in contrast, regions associated with regulation and control of emotion have been demonstrated to be hypoactive during craving episodes. Finally, several studies have demonstrated that craving is a valid predictive indicator of relapse, making it an interesting target for pharmacological and non-pharmacological treatment. Several anti-craving medications have been shown to decrease craving, including varenicline for tobacco and naltrexone for alcohol dependence. Studies examining the efficacy of other anti-craving medications for other substances are growing in numbers. Conclusions: Available data on craving support its role as a core symptom of addiction and allow for a better understanding of the underlying neurobiological substrates. Studies tend to show that it is a valid indicator of relapse during early and prolonged abstinence. Further research is needed to truly understand the complexity of the neurobiological substrates involved in craving as well as to develop new anti-craving interventions to facilitate long-term abstinence in individuals with substance use disorders...|$|E
40|$|International {{audience}} Self-medication: how {{the local}} context influences the practitioner’s perceptions and practices The French public authorities encourage {{the population to}} resort to self-medication to control health expenditure. Since risk may occur from this practice, general practitioners and pharmacists have been appointed to be the “guarantors” of a safe use for self-medication. Self-care behaviours, implying the consumption of medication without consultation, put the practitioner in an antagonistic situation between the patients’ will to be self-reliant in care use on the one hand, and the frame imposed by the public authorities on the other. This demands of the professionals that they adopt for themselves a position on such self-care practices {{in which they are}} excluded by the patient. This study aims at understanding the influence of the geographical environment on the professionals’ position and behaviour in relation to self-medication examined through the method of contextual speech. Semi-structured interviews have been conducted with 30 practitioners and 19 pharmacists from the Nantes and Saint-Nazaire areas based on questions defined by sociologists, doctors and geographers. The {{results of this study suggest}} that spatial data are salient to analyzing health professionals’ behaviour in relation to this concern of patient’s self-medication. The interviews aimed at determining the professionals’ perceptions with respect to the self-medication of their patients in terms of whether they have encouraged or on the contrary, attempted to prevent these behaviours through arguments in favour of the public policies promoting self-medication. The questions deal with the professionals’ career, the socio-economic characteristics of the patients and the motivations for their choice of place of work so as to link practices and behaviours with places.  The simultaneous study of two different urban areas enables the analysis to distinguish the effects of context from geographical invariants. The main case study was Saint Nazaire with the case of Nantes used as a mirror to enable the identification of similarities or differences. Both case studies rely on a spatial analysis of data issued of the same program: the ANR Auto-med. The choice of Saint Nazaire as the main case study is based on two observations. First, the patients’ rate of self-medication declared in a survey conducted within the ANR Auto-med program appears to be lower in Saint Nazaire than that of the regional area. Secondly, an investigation of a panel of medical consultations on the frequency of self-medication mentioned by the doctor or the patient again indicates that the area of Saint Nazaire is below the average (tab. 1). Local socio-economic conditions, culture and history influence the practices of the health professionals. The socio-economic status of the patients influences the attitude to them of the doctors, for example, in terms of their medical costs. The professionals located in the most deprived districts underline the inequalities in health generated by the de-listing of drugs known as “of comfort” from those whose costs will be reimbursed to the patient. In this context, the pharmacists seem to offer advice according to their customers’ supposed purchasing power. The health professionals located in a district concentrating a large number of poor workers express a certain concern with respect to the inequality of access to care. In this case, self-medication is an essential part of health-care behaviour because even if people provide a prescription, they are not necessarily reimbursed for certain kinds of drugs. The medical and social history of the Saint-Nazaire area has shaped the relations between patients and doctors such that a distinct community of professional practice has appeared in this area. This community is defined by a global approach towards the patient’s health, a broader concern with self-medication, and a significant emphasis given to listening and discussion during the consultations. Thus, the advice on drugs is simply part of the global relations between the patient and the GP or the pharmacist whereas in the mirror area of Nantes, this advice is delivered more as a recommendation of good practice from the “expert” to the non-expert. Interviews with pharmacists in Nantes suggest that self-medication offers a therapeutic alternative in response to a lack of listening that is prevalent among the doctors of the area. The doctors are influenced in their practices by perceived local beliefs about health. If the doctors are also native to their place of work and have always been embedded in such sets of beliefs, they are more tolerant than their fellow-doctors towards these beliefs and indeed will sometimes accept being guided by their patients when writing the prescription (although sometimes they may just add a placebo to seem to concur with the patient). The patients’ resort to self-medication is neither perceived nor accompanied in a homogeneous way from one city to another or from one district to another. In the area of Saint Nazaire, medical and social interventions have been anchored for a long time in a political and social tradition of solidarity, networking and proximity with a population weakened by the roughness and the liability of working conditions. Consequently, this situation strengthens even further the relationship between doctor and patient having thus a strong influence on self-medication. These results suggest the importance of taking into account the territorial context in the analysis of the health professionals’ behaviours opening new opportunities for studying self-medication. Tab 1. Self-medication mentioned during consultations in various areas of the region Pays de la Loire (France) Area% of answers mentioned by the patientp% of questions by the Professionalp% of appearance in the prescriptionpSaint-Nazaire-Estuaire 53, 4066, 5 < 0, 00170, 6 < 0, 001 Nantes 47, 10, 254, 80, 2260, 00, 1 Nord 4443, 80, 344, 60, 1947, 20, 29 Nantes Agglomération 39, 70, 245, 70, 1349, 90, 46 Les Mauges 41, 90, 543, 00, 2154, 80, 25 Littoral 36, 00, 155, 70, 0736, 3 < 0, 001 La Roche sur Yon 42, 50, 439, 70, 0346, 00, 22 Sud Vendée 38, 20, 340, 90, 1145, 50, 26   Les pouvoirs publics français, dans un souci de maîtrise des dépenses de santé, encouragent le recours à l’automédication de la population. Les comportements d’auto-soin, qui consistent à <b>consommer</b> de sa propre initiative un médicament sans consulter un médecin, placent ce dernier au coeur d’un antagonisme, la volonté d’autonomie des usagers confronté à celle d’encadrement des pouvoirs publics et l’obligent à se positionner face à des pratiques dont par essence il est exclu par le patient. Cette étude cherche à comprendre, par la méthode de contextualisation des discours, l’influence du milieu géographique dans les positionnements et comportements des praticiens vis à vis de l’automédication. Elle. a été réalisée à partir d’entretiens semi-directifs, selon des grilles élaborées conjointement avec des sociologues, des médecins et des géographes, auprès de 30 médecins généralistes et 19 pharmaciens des agglomérations nazairienne et nantaise. Les résultats de ce travail suggèrent l’importance de la prise en compte des données territoriales entourant soignant et soigné dans l’analyse des comportements des professionnels de santé et dans de nouvelles perspectives d’approche du recours à l’automédication. </p...|$|E

